Skip to content
乳癌
- 062001 weekly Paclitaxel×12回
- 062002 weekly Paclitaxel(day1,8,15)
- 062004 FEC60
- 062006 EC(60/600)
- 062007 Docetaxel(60mg/㎡)(day1)
- 062038 TC(Docetaxel+Cyclophosphamide)×4回
- 062040 Docetaxel(75mg/㎡)(day1)
- 062042 ddPaclitaxel×4回
- 062057 FEC100×4回
- 062070 FEC75×4回
- 062072 ddAC(60/600)×4回
- 062170 Herceptin 8(初回)
- 062180 Herceptin 6(継続)
- 062340 Eribulin (d1.8)
- 062341 Pembrolizumab+PTX+weekly CBDCA
- 062342 Pembrolizumab+PTX+tri CBDCA
- 062343 Pembrolizumab+EC(90/600)×4回
- 062345 Pembrolizumab+GEM+CBDCA
- 062346 Pembrolizumab+Abraxane
- 062348 Pembrolizumab+weekly Paclitaxel
- 062350 weekly Paclitaxel(d1,8,15)+Bevacizumab(d1,15)(初回)
- 062360 weekly Paclitaxel(d1,8,15)+Bevacizumab(d1,15)(継続)
- 062380 TCH(Docetaxel+Carboplatin+Herceptin)(継続)
- 062390 Her-TC(Docetaxel+Cyclophosphamide+Herceptin)(初回)
- 062400 Her-TC(Docetaxel+Cyclophosphamide+Harceptin)(継続)
- 062500 PHD60(Pertuzumab+Herceputin+Docetaxel)(初回)
- 062510 PHD60(Pertuzumab+Herceptin+Docetaxel)(2回~)
- 062530 PHD75(Pertuzumab+Herceptin+Docetaxel)(2回~)
- 062550 Kadcyla(T-DM1)2回目以降
- 062561 PH+weekly Paclitaxel×12回
- 062590 【限定使用】PH(パージェタ+ハーセプチン)(2回目~)
- 062610 Abraxane(d1,8,15)+Atezolizumab(d1,15)
- 062660 ENHERTU(T-DXd)
- 062710 TCHP(DOC+CBDCA+TRA+PER)(初回+2回目)
- 062720 TCHP(DOC+CBDCA+TRA+PER)(3~6回目)
- 062730 EC(90/600)×4回
- 900020 Pembrolizumab(200㎎/body)